Lunch Innovation Theaters (Non-Accredited): Treating MDD with a Rapid-Acting Antidepressant That Modulates Both Glutamatergic and Monoaminergic Pathways

Lunch will be served. Seating is limited to 250 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs. Presenters: Jeremy A. Schreiber, APRN, PMHNP-BC; Laura K. Melaro, DNP, APRN, FNP-BC, PMHNP-BC This presentation is provided by Axsome Therapeutics, Inc.